STOK Competitors & Alternatives
Compare Stoke Therapeutics Inc with similar stocks in the same industry
Biotechnology
STOK
Main Stock$26.06
Tradestie Score
67
Market Cap
$1.29B
Revenue Growth
-0.3%
Analyst Upside
+78.3%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$13.96
|
$1.78B | - | 34 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$15.66
|
$1.78B | - | 50 | Compare |
|
TWST
Twist Bioscience Corporation Common Stock
|
$189.56
|
$1.77B | - | 48 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.30
|
$1.74B | - | 57 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$32.29
|
$1.68B | - | 59 | Compare |
|
MNKD
Mannkind Corporation
|
$3.75
|
$1.65B | - | 36 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$41.21
|
$1.63B | - | 53 | Compare |
|
BHVN
Biohaven Ltd.
|
$13.00
|
$1.57B | - | 52 | Compare |
|
VCEL
Vericel Corporation
|
$39.97
|
$1.56B | 83.6 | 65 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$90.50
|
$1.55B | - | 67 | Compare |
More STOK Analysis
Data updated: Oct 02, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry